ClearPoint Neuro CLPT Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$9.55M-22.7% | -$7.79M-32.2% | -$5.89M-0.9% | -$5.84M+3.1% | -$6.03M-11.9% | ||
| $86K-65.5% | $249K+277% | $66K-83.3% | $396K+284% | $103K-57.1% | ||
| $2.22M+12.0% | $1.98M-2.0% | $2.02M-10.9% | $2.27M+18.9% | $1.91M+12.0% | ||
| $42K+82.6% | $23K-41.0% | $39K+85.7% | $21K— | $0— | ||
| -$95K— | —— | —— | —— | $217K— | ||
| $2.02M+164% | $765K+394% | -$260K-143% | $609K+172% | -$846K-181% | ||
| $125K+43.7% | $87K-82.5% | $498K+223% | -$404K-418% | -$78K+74.8% | ||
| -$437K+93.0% | -$6.27M— | —— | —— | -$2.88M-266% | ||
| -$653K— | —— | $560K+84.2% | $304K+281% | -$168K+3.4% | ||
| $172K+169% | -$250K— | —— | —— | -$581K— | ||
| $504K— | —— | —— | —— | $0— | ||
| -$391K-32.1% | -$296K-20.8% | -$245K-3.4% | -$237K-1.3% | -$234K0.0% | ||
| -$7.97M+33.9% | -$12.06M-286% | -$3.12M-22.3% | -$2.55M+58.7% | -$6.17M-397% | ||
| $645K+1,216% | $49K-75.4% | $199K+119% | $91K-50.3% | $183K-30.4% | ||
| —— | $284.25K0.0% | $284.25K0.0% | $284.25K0.0% | $284.25K— | ||
| -$645K-159% | $1.09M+647% | -$199K-119% | -$91K+50.3% | -$183K+30.4% | ||
| $148K— | —— | —— | $3.26M— | $0— | ||
| $1.99M+922% | $195K— | $0-100% | $356K-72.7% | $1.31M+1,454% | ||
| -$1.85M-109% | $19.56M— | $0-100% | $31.98M+2,448% | -$1.36M-3,781% | ||
| -$10.46M-222% | $8.57M— | —— | $29.33M+480% | -$7.72M-425% | ||
| $525K+25.6% | $418K+31.4% | $318K+84.9% | $172K— | $0— | ||
| $0— | $0-100% | $57K+375% | $12K— | $0-100% | ||
| $42K+82.6% | $23K-41.0% | $39K+85.7% | $21K— | $0— | ||
| $504K— | —— | —— | —— | $0— | ||
| -$391K-32.1% | -$296K-20.8% | -$245K-3.4% | -$237K-1.3% | -$234K0.0% | ||
| $71K+2,267% | $3K-98.4% | $192K— | $0— | $0— | ||
| -$653K— | —— | $560K+84.2% | $304K+281% | -$168K+3.4% | ||
| $525K+25.6% | $418K+31.4% | $318K+84.9% | $172K— | $0— | ||
| -$95K— | —— | —— | —— | $217K— | ||
| $0— | —— | —— | —— | $78K— | ||
| $172K+169% | -$250K— | —— | —— | -$581K— | ||
| -$391K-32.1% | -$296K-20.8% | -$245K-3.4% | -$237K-1.3% | -$234K0.0% | ||
| -$8.61M+28.8% | -$12.1M-265% | -$3.32M-25.6% | -$2.64M+58.4% | -$6.36M-322% | ||
| -$8.61M+28.8% | -$12.1M-265% | -$3.32M-25.6% | -$2.64M+58.4% | -$6.36M-322% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does ClearPoint Neuro generate?
- ClearPoint Neuro (CLPT) generated -$25.7M in operating cash flow over the trailing twelve months.
- What is ClearPoint Neuro's free cash flow?
- After $984.0K of capital expenditures, ClearPoint Neuro's free cash flow was -$26.7M over the trailing twelve months, down 127.3% year over year.
- Where does ClearPoint Neuro's cash flow data come from?
- Every line is extracted from ClearPoint Neuro's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
